These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6993000)

  • 1. Tumor promotion and preneoplastic progression.
    Colburn NH
    Carcinog Compr Surv; 1980; 5():33-56. PubMed ID: 6993000
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response.
    Bannasch P; Zerban H
    IARC Sci Publ; 1992; (116):389-427. PubMed ID: 1428091
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth.
    Russell DH
    Drug Metab Rev; 1985; 16(1-2):1-88. PubMed ID: 3905315
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal ornithine decarboxylase, polyamines, cell proliferation, and tumor promotion.
    Lowe NJ
    Arch Dermatol; 1980 Jul; 116(7):822-5. PubMed ID: 6994661
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathological and biochemical aspects of tumour promotion.
    Hicks RM
    Carcinogenesis; 1983 Oct; 4(10):1209-14. PubMed ID: 6616751
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of tumor transformation of tissue. I. Indications of the degree of autonomy and their appearance].
    Saliamon LS
    Tsitologiia; 1969 Nov; 11(11):1366-78. PubMed ID: 4315855
    [No Abstract]   [Full Text] [Related]  

  • 8. Teleocidin: new naturally occurring tumor promoter.
    Sugimura T; Fujiki H; Mori M; Nakayasu M; Terada M; Umezawa K; Moore RE
    Carcinog Compr Surv; 1982; 7():69-73. PubMed ID: 6802497
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
    Slaga TJ; Fischer SM; Weeks CE; Nelson K; Mamrack M; Klein-Szanto AJ
    Carcinog Compr Surv; 1982; 7():19-34. PubMed ID: 7039828
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of ornithine decarboxylase activity to proliferation and differentiation of L6 muscle cells.
    Stoscheck CM; Florini JR; Richman RA
    J Cell Physiol; 1980 Jan; 102(1):11-8. PubMed ID: 7372717
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic and chromosomal alterations in cell cultures as indicators of tumor-promoting activity.
    Fusenig NE; Dzarlieva RT
    Carcinog Compr Surv; 1982; 7():201-16. PubMed ID: 7039829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Induction of tumor-like growth in a culture of mycelial fungi--a potential experimental model of multistage carcinogenesis].
    Zhemaletdinov FG; Kabiev OK; Balmukhanov SB
    Vopr Onkol; 1988; 34(8):960-6. PubMed ID: 3420839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats.
    Tanaka T; Kojima T; Kawamori T; Yoshimi N; Mori H
    Cancer Res; 1993 Jun; 53(12):2775-9. PubMed ID: 8504418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of ornithine decarboxylase in urinary bladder carcinoma cells.
    Izumi K; Hirao Y; Hopp L; Oyasu R
    Cancer Res; 1981 Feb; 41(2):405-9. PubMed ID: 7448785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
    Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
    Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tumor-promoting phorbol diesters on neoplastic progression of Syrian hamster embryo cells.
    O'Brien TG; Saladik D; Diamond L
    Cancer Res; 1982 Apr; 42(4):1233-8. PubMed ID: 7059999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens.
    Matsushima M; Bryan GT
    Cancer Res; 1980 Jun; 40(6):1897-901. PubMed ID: 7371022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory steroids: potent inhibitors of tumor promotion.
    Slaga TJ
    Carcinog Compr Surv; 1980; 5():111-26. PubMed ID: 6992993
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood polyamine levels after oral ornithine load, a diagnostic marker of hyperproliferative premalignant and malignant stages in a model of colon carcinogenesis.
    Schleiffer R; Duranton B; Gossé F; Hasselmann M; Raul F
    Cancer Detect Prev; 2000; 24(6):542-8. PubMed ID: 11198268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.